Machine-learning-derived classifier predicts absence of persistent pain after breast cancer surgery with high accuracy
Background Prevention of persistent pain following breast cancer surgery, via early identification of patients at high risk, is a clinical need. Supervised machine-learning was used to identify parameters that predict persistence of significant pain. Methods Over 500 demographic, clinical and psycho...
Gespeichert in:
Veröffentlicht in: | Breast cancer research and treatment 2018-09, Vol.171 (2), p.399-411 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 411 |
---|---|
container_issue | 2 |
container_start_page | 399 |
container_title | Breast cancer research and treatment |
container_volume | 171 |
creator | Lötsch, Jörn Sipilä, Reetta Tasmuth, Tiina Kringel, Dario Estlander, Ann-Mari Meretoja, Tuomo Kalso, Eija Ultsch, Alfred |
description | Background
Prevention of persistent pain following breast cancer surgery, via early identification of patients at high risk, is a clinical need. Supervised machine-learning was used to identify parameters that predict persistence of significant pain.
Methods
Over 500 demographic, clinical and psychological parameters were acquired up to 6 months after surgery from 1,000 women (aged 28–75 years) who were treated for breast cancer. Pain was assessed using an 11-point numerical rating scale before surgery and at months 1, 6, 12, 24, and 36. The ratings at months 12, 24, and 36 were used to allocate patents to either “persisting pain” or “non-persisting pain” groups. Unsupervised machine learning was applied to map the parameters to these diagnoses.
Results
A symbolic rule-based classifier tool was created that comprised 21 single or aggregated parameters, including demographic features, psychological and pain-related parameters, forming a questionnaire with “yes/no” items (decision rules). If at least 10 of the 21 rules applied, persisting pain was predicted at a cross-validated accuracy of 86% and a negative predictive value of approximately 95%.
Conclusions
The present machine-learned analysis showed that, even with a large set of parameters acquired from a large cohort, early identification of these patients is only partly successful. This indicates that more parameters are needed for accurate prediction of persisting pain. However, with the current parameters it is possible, with a certainty of almost 95%, to exclude the possibility of persistent pain developing in a woman being treated for breast cancer. |
doi_str_mv | 10.1007/s10549-018-4841-8 |
format | Article |
fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6096884</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A548869009</galeid><sourcerecordid>A548869009</sourcerecordid><originalsourceid>FETCH-LOGICAL-c568t-c9619b31d91b78a0d5b6ffa288b6f7180aa47034630bddf5a484f354b1df0f873</originalsourceid><addsrcrecordid>eNp1kk1v1DAQhiMEokvhB3BBlpAQl5RxEn_kglRVfElFXOBsTZzxxlXWWexk0f57vNrSdhHIh5E8z7z2zLxF8ZLDBQdQ7xIH0bQlcF02uuGlflSsuFB1qSquHhcr4FKVUoM8K56ldAMArYL2aXFWtVpJ2YpVsfuKdvCBypEwBh_WZU_R76hndsSUvPMU2TZS7-2cGHaJgiU2ObalmHyaKcxsiz4wdHMmu0iYZmYxU5GlJa4p7tkvPw9s8OuBobVLRLt_XjxxOCZ6cRvPix8fP3y_-lxef_v05eryurRC6rm0reRtV_O-5Z3SCL3opHNYaZ2j4hoQGwV1I2vo-t4JzGNwtWg63jtwWtXnxfuj7nbpNtTb_N2Io9lGv8G4NxN6c5oJfjDraWcktFLrJgu8vRWI08-F0mw2PlkaRww0LclUILgUstF1Rl__hd5MSwy5vQMFSugG4J5a40jGBzfld-1B1FyKRmvZ5i1l6uIfVD49bbydAjmf708K3jwoGAjHeUjTuMx-CukU5EfQximlSO5uGBzMwVXm6CqTXWUOrjI617x6OMW7ij82ykB1BFJOhbzz-9b_r_obs5fYQQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2050758400</pqid></control><display><type>article</type><title>Machine-learning-derived classifier predicts absence of persistent pain after breast cancer surgery with high accuracy</title><source>Springer Nature - Complete Springer Journals</source><creator>Lötsch, Jörn ; Sipilä, Reetta ; Tasmuth, Tiina ; Kringel, Dario ; Estlander, Ann-Mari ; Meretoja, Tuomo ; Kalso, Eija ; Ultsch, Alfred</creator><creatorcontrib>Lötsch, Jörn ; Sipilä, Reetta ; Tasmuth, Tiina ; Kringel, Dario ; Estlander, Ann-Mari ; Meretoja, Tuomo ; Kalso, Eija ; Ultsch, Alfred</creatorcontrib><description>Background
Prevention of persistent pain following breast cancer surgery, via early identification of patients at high risk, is a clinical need. Supervised machine-learning was used to identify parameters that predict persistence of significant pain.
Methods
Over 500 demographic, clinical and psychological parameters were acquired up to 6 months after surgery from 1,000 women (aged 28–75 years) who were treated for breast cancer. Pain was assessed using an 11-point numerical rating scale before surgery and at months 1, 6, 12, 24, and 36. The ratings at months 12, 24, and 36 were used to allocate patents to either “persisting pain” or “non-persisting pain” groups. Unsupervised machine learning was applied to map the parameters to these diagnoses.
Results
A symbolic rule-based classifier tool was created that comprised 21 single or aggregated parameters, including demographic features, psychological and pain-related parameters, forming a questionnaire with “yes/no” items (decision rules). If at least 10 of the 21 rules applied, persisting pain was predicted at a cross-validated accuracy of 86% and a negative predictive value of approximately 95%.
Conclusions
The present machine-learned analysis showed that, even with a large set of parameters acquired from a large cohort, early identification of these patients is only partly successful. This indicates that more parameters are needed for accurate prediction of persisting pain. However, with the current parameters it is possible, with a certainty of almost 95%, to exclude the possibility of persistent pain developing in a woman being treated for breast cancer.</description><identifier>ISSN: 0167-6806</identifier><identifier>EISSN: 1573-7217</identifier><identifier>DOI: 10.1007/s10549-018-4841-8</identifier><identifier>PMID: 29876695</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Analysis ; Breast cancer ; Cancer research ; Cancer surgery ; Clinical Trial ; Data science ; Learning algorithms ; Machine learning ; Mastectomy ; Medicine ; Medicine & Public Health ; Oncology ; Pain ; Pain management ; Surgery</subject><ispartof>Breast cancer research and treatment, 2018-09, Vol.171 (2), p.399-411</ispartof><rights>The Author(s) 2018</rights><rights>COPYRIGHT 2018 Springer</rights><rights>Breast Cancer Research and Treatment is a copyright of Springer, (2018). All Rights Reserved. © 2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c568t-c9619b31d91b78a0d5b6ffa288b6f7180aa47034630bddf5a484f354b1df0f873</citedby><cites>FETCH-LOGICAL-c568t-c9619b31d91b78a0d5b6ffa288b6f7180aa47034630bddf5a484f354b1df0f873</cites><orcidid>0000-0002-5818-6958</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s10549-018-4841-8$$EPDF$$P50$$Gspringer$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s10549-018-4841-8$$EHTML$$P50$$Gspringer$$Hfree_for_read</linktohtml><link.rule.ids>230,314,776,780,881,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29876695$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lötsch, Jörn</creatorcontrib><creatorcontrib>Sipilä, Reetta</creatorcontrib><creatorcontrib>Tasmuth, Tiina</creatorcontrib><creatorcontrib>Kringel, Dario</creatorcontrib><creatorcontrib>Estlander, Ann-Mari</creatorcontrib><creatorcontrib>Meretoja, Tuomo</creatorcontrib><creatorcontrib>Kalso, Eija</creatorcontrib><creatorcontrib>Ultsch, Alfred</creatorcontrib><title>Machine-learning-derived classifier predicts absence of persistent pain after breast cancer surgery with high accuracy</title><title>Breast cancer research and treatment</title><addtitle>Breast Cancer Res Treat</addtitle><addtitle>Breast Cancer Res Treat</addtitle><description>Background
Prevention of persistent pain following breast cancer surgery, via early identification of patients at high risk, is a clinical need. Supervised machine-learning was used to identify parameters that predict persistence of significant pain.
Methods
Over 500 demographic, clinical and psychological parameters were acquired up to 6 months after surgery from 1,000 women (aged 28–75 years) who were treated for breast cancer. Pain was assessed using an 11-point numerical rating scale before surgery and at months 1, 6, 12, 24, and 36. The ratings at months 12, 24, and 36 were used to allocate patents to either “persisting pain” or “non-persisting pain” groups. Unsupervised machine learning was applied to map the parameters to these diagnoses.
Results
A symbolic rule-based classifier tool was created that comprised 21 single or aggregated parameters, including demographic features, psychological and pain-related parameters, forming a questionnaire with “yes/no” items (decision rules). If at least 10 of the 21 rules applied, persisting pain was predicted at a cross-validated accuracy of 86% and a negative predictive value of approximately 95%.
Conclusions
The present machine-learned analysis showed that, even with a large set of parameters acquired from a large cohort, early identification of these patients is only partly successful. This indicates that more parameters are needed for accurate prediction of persisting pain. However, with the current parameters it is possible, with a certainty of almost 95%, to exclude the possibility of persistent pain developing in a woman being treated for breast cancer.</description><subject>Analysis</subject><subject>Breast cancer</subject><subject>Cancer research</subject><subject>Cancer surgery</subject><subject>Clinical Trial</subject><subject>Data science</subject><subject>Learning algorithms</subject><subject>Machine learning</subject><subject>Mastectomy</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Oncology</subject><subject>Pain</subject><subject>Pain management</subject><subject>Surgery</subject><issn>0167-6806</issn><issn>1573-7217</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp1kk1v1DAQhiMEokvhB3BBlpAQl5RxEn_kglRVfElFXOBsTZzxxlXWWexk0f57vNrSdhHIh5E8z7z2zLxF8ZLDBQdQ7xIH0bQlcF02uuGlflSsuFB1qSquHhcr4FKVUoM8K56ldAMArYL2aXFWtVpJ2YpVsfuKdvCBypEwBh_WZU_R76hndsSUvPMU2TZS7-2cGHaJgiU2ObalmHyaKcxsiz4wdHMmu0iYZmYxU5GlJa4p7tkvPw9s8OuBobVLRLt_XjxxOCZ6cRvPix8fP3y_-lxef_v05eryurRC6rm0reRtV_O-5Z3SCL3opHNYaZ2j4hoQGwV1I2vo-t4JzGNwtWg63jtwWtXnxfuj7nbpNtTb_N2Io9lGv8G4NxN6c5oJfjDraWcktFLrJgu8vRWI08-F0mw2PlkaRww0LclUILgUstF1Rl__hd5MSwy5vQMFSugG4J5a40jGBzfld-1B1FyKRmvZ5i1l6uIfVD49bbydAjmf708K3jwoGAjHeUjTuMx-CukU5EfQximlSO5uGBzMwVXm6CqTXWUOrjI617x6OMW7ij82ykB1BFJOhbzz-9b_r_obs5fYQQ</recordid><startdate>20180901</startdate><enddate>20180901</enddate><creator>Lötsch, Jörn</creator><creator>Sipilä, Reetta</creator><creator>Tasmuth, Tiina</creator><creator>Kringel, Dario</creator><creator>Estlander, Ann-Mari</creator><creator>Meretoja, Tuomo</creator><creator>Kalso, Eija</creator><creator>Ultsch, Alfred</creator><general>Springer US</general><general>Springer</general><general>Springer Nature B.V</general><scope>C6C</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>K9-</scope><scope>K9.</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-5818-6958</orcidid></search><sort><creationdate>20180901</creationdate><title>Machine-learning-derived classifier predicts absence of persistent pain after breast cancer surgery with high accuracy</title><author>Lötsch, Jörn ; Sipilä, Reetta ; Tasmuth, Tiina ; Kringel, Dario ; Estlander, Ann-Mari ; Meretoja, Tuomo ; Kalso, Eija ; Ultsch, Alfred</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c568t-c9619b31d91b78a0d5b6ffa288b6f7180aa47034630bddf5a484f354b1df0f873</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Analysis</topic><topic>Breast cancer</topic><topic>Cancer research</topic><topic>Cancer surgery</topic><topic>Clinical Trial</topic><topic>Data science</topic><topic>Learning algorithms</topic><topic>Machine learning</topic><topic>Mastectomy</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Oncology</topic><topic>Pain</topic><topic>Pain management</topic><topic>Surgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lötsch, Jörn</creatorcontrib><creatorcontrib>Sipilä, Reetta</creatorcontrib><creatorcontrib>Tasmuth, Tiina</creatorcontrib><creatorcontrib>Kringel, Dario</creatorcontrib><creatorcontrib>Estlander, Ann-Mari</creatorcontrib><creatorcontrib>Meretoja, Tuomo</creatorcontrib><creatorcontrib>Kalso, Eija</creatorcontrib><creatorcontrib>Ultsch, Alfred</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Breast cancer research and treatment</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lötsch, Jörn</au><au>Sipilä, Reetta</au><au>Tasmuth, Tiina</au><au>Kringel, Dario</au><au>Estlander, Ann-Mari</au><au>Meretoja, Tuomo</au><au>Kalso, Eija</au><au>Ultsch, Alfred</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Machine-learning-derived classifier predicts absence of persistent pain after breast cancer surgery with high accuracy</atitle><jtitle>Breast cancer research and treatment</jtitle><stitle>Breast Cancer Res Treat</stitle><addtitle>Breast Cancer Res Treat</addtitle><date>2018-09-01</date><risdate>2018</risdate><volume>171</volume><issue>2</issue><spage>399</spage><epage>411</epage><pages>399-411</pages><issn>0167-6806</issn><eissn>1573-7217</eissn><abstract>Background
Prevention of persistent pain following breast cancer surgery, via early identification of patients at high risk, is a clinical need. Supervised machine-learning was used to identify parameters that predict persistence of significant pain.
Methods
Over 500 demographic, clinical and psychological parameters were acquired up to 6 months after surgery from 1,000 women (aged 28–75 years) who were treated for breast cancer. Pain was assessed using an 11-point numerical rating scale before surgery and at months 1, 6, 12, 24, and 36. The ratings at months 12, 24, and 36 were used to allocate patents to either “persisting pain” or “non-persisting pain” groups. Unsupervised machine learning was applied to map the parameters to these diagnoses.
Results
A symbolic rule-based classifier tool was created that comprised 21 single or aggregated parameters, including demographic features, psychological and pain-related parameters, forming a questionnaire with “yes/no” items (decision rules). If at least 10 of the 21 rules applied, persisting pain was predicted at a cross-validated accuracy of 86% and a negative predictive value of approximately 95%.
Conclusions
The present machine-learned analysis showed that, even with a large set of parameters acquired from a large cohort, early identification of these patients is only partly successful. This indicates that more parameters are needed for accurate prediction of persisting pain. However, with the current parameters it is possible, with a certainty of almost 95%, to exclude the possibility of persistent pain developing in a woman being treated for breast cancer.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>29876695</pmid><doi>10.1007/s10549-018-4841-8</doi><tpages>13</tpages><orcidid>https://orcid.org/0000-0002-5818-6958</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0167-6806 |
ispartof | Breast cancer research and treatment, 2018-09, Vol.171 (2), p.399-411 |
issn | 0167-6806 1573-7217 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6096884 |
source | Springer Nature - Complete Springer Journals |
subjects | Analysis Breast cancer Cancer research Cancer surgery Clinical Trial Data science Learning algorithms Machine learning Mastectomy Medicine Medicine & Public Health Oncology Pain Pain management Surgery |
title | Machine-learning-derived classifier predicts absence of persistent pain after breast cancer surgery with high accuracy |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T15%3A56%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Machine-learning-derived%20classifier%20predicts%20absence%20of%20persistent%20pain%20after%20breast%20cancer%20surgery%20with%20high%20accuracy&rft.jtitle=Breast%20cancer%20research%20and%20treatment&rft.au=L%C3%B6tsch,%20J%C3%B6rn&rft.date=2018-09-01&rft.volume=171&rft.issue=2&rft.spage=399&rft.epage=411&rft.pages=399-411&rft.issn=0167-6806&rft.eissn=1573-7217&rft_id=info:doi/10.1007/s10549-018-4841-8&rft_dat=%3Cgale_pubme%3EA548869009%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2050758400&rft_id=info:pmid/29876695&rft_galeid=A548869009&rfr_iscdi=true |